Physician profile
Daniel H Jacobson
NPI 1639249923
$10,435.96
in general payments reported to CMS, 2019-2025
32 companies · $197 in 2025
The $197 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,096 · 2020: $1,239 · 2021: $2,151 · 2022: $564 · 2023: $678 · 2024: $511 · 2025: $197.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,344 · Education: $42.31.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.95 |
| Education | $42.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $6,818.77 | 2019-2022 | |
| Medtronic, INC. | $662.64 | 2021-2022 | |
| Abbvie INC. | $565.82 | 2019-2024 | |
| Hologic Sales and Service, LLC | $322.56 | 2022-2025 | Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Aptima |
| Astellas Pharma US INC | $283.17 | 2022-2024 | Veozah, Cresemba |
| Bayer Healthcare Pharmaceuticals INC. | $238.16 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $206.64 | 2021-2023 | |
| Alexion Pharmaceuticals, INC. | $149.46 | 2019 | |
| Allergan, INC. | $123.47 | 2019-2020 | |
| Exeltis, USA INC. | $119.24 | 2020-2023 | Slynd |
| Pfizer INC. | $118.13 | 2019-2023 | |
| Avanos Medical | $92.75 | 2019 | |
| Therapeuticsmd, INC. | $91.68 | 2019-2022 | |
| Coopersurgical, INC. | $88.40 | 2021-2023 | Paragard T 380a |
| Organon LLC | $83.91 | 2022-2024 | Nexplanon |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $68.52 | 2019-2023 | Gardasil 9 |
| Ethicon US, LLC | $50.28 | 2021-2024 | Stratafix, Surgiflo Hemostatic Matrix |
| Lupin INC. | $42.82 | 2020-2021 | |
| Avion Pharmaceuticals | $39.08 | 2021 | |
| Laborie Medical Technologies Corp. | $37.55 | 2024 | |
| Amag Pharmaceuticals, INC. | $30.01 | 2019-2020 | |
| Covidien LP | $26.89 | 2019 | |
| Baxter Healthcare | $23.10 | 2024 | Perclot |
| Convatec INC. | $22.55 | 2024 | |
| Innovation Technologies INC | $21.81 | 2023 | Irrisept |
| Exact Sciences Corporation | $19.97 | 2023 | Cologuard Collection Kit |
| Gynesonics, INC. | $17.04 | 2024 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Roche Diagnostics Corporation | $15.56 | 2019 | |
| Conmed Corporation | $15.35 | 2023 | Visiclear |
| Sage Therapeutics, LLC | $13.87 | 2024 | |
| Millicent US INC | $13.81 | 2024 | Intrarosa, Femring |
| Meditrina | $12.95 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Jacobson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.